<DOC>
	<DOCNO>NCT01731990</DOCNO>
	<brief_summary>This study design assess safety , tolerability efficacy ACZ885 leg artery structure physical activity patient atherosclerotic peripheral artery disease leg pain walking .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy ACZ885 Leg Artery Structure Patients With Peripheral Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>Must sign informed consent form . Must age 18 80 Must experience leg pain associate walk walk less 400 meter ankle brachial index 0.50 0.85 Must stable asprin statin dose least 6 week Blood pressure within range specificed protocol Able communicate well Investigator understand comply study procedure Recent use experimental drug Pregnant nursing woman Women child bear potential unless willing use contraception detail protocol Can walk 50 meter People restrict medication list protocol Any open nonhealing wound 3 month study start infection within 2 week study start Significant heart disease Uncontrolled diabetes Significant kidney liver disease Live vaccination 3 month study start History untreated tuberculosis active tuberculosis ( TB ) Patients metal body ( exclude due MRI scan ) detail protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Peripheral artery disease</keyword>
	<keyword>Intermittent claudication</keyword>
	<keyword>magnetic resonance imaging</keyword>
</DOC>